Searchable abstracts of presentations at key conferences in endocrinology

ea0038p247 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Is polycythaemia a marker of an increased cardiovascular risk in transmen?

Naing Aye , Lei Lily , Jones Katie , Barrett James , Seal Leighton

A retrospective single centre audit was conducted on the effects of polycythaemia in trans-male and native male.Polycythaemia is a recognised side effect of testosterone treatment. It could be viewed as a maker of excess testosterone action. We examined whether lipid profiles as a marker of cardiovascular risk differed in a population of polycythaemic transmen (TM) and native males (NM).Forty-six NM and 12 TM were identified to hav...